Real-world survival of colon cancer after radical surgery: A single-institutional retrospective analysis

The survival rate for colon cancer after radical surgery has been the focus of extensive debate. To assess the postoperative survival and prognostic factors for overall survival (OS), we collected clinicopathological information for 2,655 patients. The survival time and potential risk factors for OS...

Full description

Bibliographic Details
Main Authors: Xiangyi Pang, Benjie Xu, Jie Lian, Ren Wang, Xin Wang, Jiayue Shao, Shuli Tang, Haibo Lu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.914076/full
_version_ 1811261394088099840
author Xiangyi Pang
Benjie Xu
Jie Lian
Ren Wang
Xin Wang
Jiayue Shao
Shuli Tang
Haibo Lu
author_facet Xiangyi Pang
Benjie Xu
Jie Lian
Ren Wang
Xin Wang
Jiayue Shao
Shuli Tang
Haibo Lu
author_sort Xiangyi Pang
collection DOAJ
description The survival rate for colon cancer after radical surgery has been the focus of extensive debate. To assess the postoperative survival and prognostic factors for overall survival (OS), we collected clinicopathological information for 2,655 patients. The survival time and potential risk factors for OS were analyzed by using Kaplan–Meier curves, Cox proportional hazards models, best subset regression (BSR), and least absolute shrinkage and selection operator (LASSO). The 5-year survival rates of stage I–IV colon cancer were 96.6%, 88.7%, 69.9%, and 34.3%, respectively. Adjuvant chemotherapy improved the survival rate (90.4% vs. 82.4%, with versus without adjuvant chemotherapy, respectively) in stage II patients with high-risk factors. Elevated preoperative carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9) were significantly associated with worse OS compared with patients without these elevations. Less than 12 versus more than 12 harvested lymph nodes (LNs) affected prognosis (84.6% vs. 89.7%, respectively). Regarding the lymph node ratio (LNR), the 5-year OS rate was 89.2%, 71.5%, 55.8%, and 34.5% in patients with LNR values of 0, 0.3, 0.3–0.7, and >0.7, respectively. We constructed a nomogram comprising the independent factors associated with survival to better predict prognosis. On the basis of these findings, we propose that stage II colon cancer patients without high-risk factors and with both elevated preoperative CEA and CA199 should receive adjuvant therapy. Furthermore, the LNR could complement TNM staging in patients with <12 harvested LNs. Our nomogram might be useful as a new prognosis prediction system for colon cancer patients.
first_indexed 2024-04-12T19:03:38Z
format Article
id doaj.art-b5403f5c740c45cb9d6983fa27cf3754
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-04-12T19:03:38Z
publishDate 2022-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-b5403f5c740c45cb9d6983fa27cf37542022-12-22T03:20:05ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-09-011210.3389/fonc.2022.914076914076Real-world survival of colon cancer after radical surgery: A single-institutional retrospective analysisXiangyi PangBenjie XuJie LianRen WangXin WangJiayue ShaoShuli TangHaibo LuThe survival rate for colon cancer after radical surgery has been the focus of extensive debate. To assess the postoperative survival and prognostic factors for overall survival (OS), we collected clinicopathological information for 2,655 patients. The survival time and potential risk factors for OS were analyzed by using Kaplan–Meier curves, Cox proportional hazards models, best subset regression (BSR), and least absolute shrinkage and selection operator (LASSO). The 5-year survival rates of stage I–IV colon cancer were 96.6%, 88.7%, 69.9%, and 34.3%, respectively. Adjuvant chemotherapy improved the survival rate (90.4% vs. 82.4%, with versus without adjuvant chemotherapy, respectively) in stage II patients with high-risk factors. Elevated preoperative carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9) were significantly associated with worse OS compared with patients without these elevations. Less than 12 versus more than 12 harvested lymph nodes (LNs) affected prognosis (84.6% vs. 89.7%, respectively). Regarding the lymph node ratio (LNR), the 5-year OS rate was 89.2%, 71.5%, 55.8%, and 34.5% in patients with LNR values of 0, 0.3, 0.3–0.7, and >0.7, respectively. We constructed a nomogram comprising the independent factors associated with survival to better predict prognosis. On the basis of these findings, we propose that stage II colon cancer patients without high-risk factors and with both elevated preoperative CEA and CA199 should receive adjuvant therapy. Furthermore, the LNR could complement TNM staging in patients with <12 harvested LNs. Our nomogram might be useful as a new prognosis prediction system for colon cancer patients.https://www.frontiersin.org/articles/10.3389/fonc.2022.914076/fullcolon cancerradical surgerysurvival ratenomogramprognostic factors
spellingShingle Xiangyi Pang
Benjie Xu
Jie Lian
Ren Wang
Xin Wang
Jiayue Shao
Shuli Tang
Haibo Lu
Real-world survival of colon cancer after radical surgery: A single-institutional retrospective analysis
Frontiers in Oncology
colon cancer
radical surgery
survival rate
nomogram
prognostic factors
title Real-world survival of colon cancer after radical surgery: A single-institutional retrospective analysis
title_full Real-world survival of colon cancer after radical surgery: A single-institutional retrospective analysis
title_fullStr Real-world survival of colon cancer after radical surgery: A single-institutional retrospective analysis
title_full_unstemmed Real-world survival of colon cancer after radical surgery: A single-institutional retrospective analysis
title_short Real-world survival of colon cancer after radical surgery: A single-institutional retrospective analysis
title_sort real world survival of colon cancer after radical surgery a single institutional retrospective analysis
topic colon cancer
radical surgery
survival rate
nomogram
prognostic factors
url https://www.frontiersin.org/articles/10.3389/fonc.2022.914076/full
work_keys_str_mv AT xiangyipang realworldsurvivalofcoloncancerafterradicalsurgeryasingleinstitutionalretrospectiveanalysis
AT benjiexu realworldsurvivalofcoloncancerafterradicalsurgeryasingleinstitutionalretrospectiveanalysis
AT jielian realworldsurvivalofcoloncancerafterradicalsurgeryasingleinstitutionalretrospectiveanalysis
AT renwang realworldsurvivalofcoloncancerafterradicalsurgeryasingleinstitutionalretrospectiveanalysis
AT xinwang realworldsurvivalofcoloncancerafterradicalsurgeryasingleinstitutionalretrospectiveanalysis
AT jiayueshao realworldsurvivalofcoloncancerafterradicalsurgeryasingleinstitutionalretrospectiveanalysis
AT shulitang realworldsurvivalofcoloncancerafterradicalsurgeryasingleinstitutionalretrospectiveanalysis
AT haibolu realworldsurvivalofcoloncancerafterradicalsurgeryasingleinstitutionalretrospectiveanalysis